Back HCV Disease Progression Fibrosis/Cirrhosis

Fibrosis & Cirrhosis

FibroScan Liver Stiffness Measurement Predicts Liver Failure and Death

Transient elastography, better known as FibroScan, is an accurate method for predicting liver-related clinical events and death in HIV positive people coinfected with hepatitis C virus (HCV), according to a study described in the July 2012 issue of Hepatology.

Read more:

Insulin Resistance Linked to Liver Disease Progression in HIV/HCV Coinfected Patients

Insulin resistance is common among HIV positive people with hepatitis C virus (HCV) coinfection and is strongly associated with progression to liver fibrosis over time, Canadian researchers reported in the June 27, 2012, advance online edition of AIDS.alt

Read more:

Coffee May Reduce Fibrosis in People with Fatty Liver Disease

A new study published in the February 2012 issue of Hepatology adds to the evidence that drinking caffeinated coffee may help slow or prevent progression of liver damage, this time in people with nonalcoholic fatty liver disease (NAFLD).alt

Read more:

Hepatitis C Treatment May Improve Liver Fibrosis Even Without a Cure

Experiencing a large decrease in hepatitis C virus (HCV) viral load after starting interferon-based therapy was associated with reduced liver inflammation and lower risk of fibrosis progression, even among patients who did not achieve sustained virological response, researchers reported in the June 12, 2012, advance edition of the American Journal of Gastroenterology.alt

Read more:

AASLD 2011: Do Hepatitis C Patients with Cirrhosis Benefit from Adding Telaprevir?

Adding telaprevir to pegylated interferon/ribavirin increased the likelihood of a cure for genotype 1 chronic hepatitis C patients with liver cirrhosis in the REALIZE trial, according to data presented at the American Association for the Study of Liver Diseases Liver Meeting (AASLD 2011) last week in San Francisco.

Read more: